We have examined the roles of 2 putative tumor-suppressor genes, the p
16 and p15 inhibitor-of-cyclin-dependent-kinase genes, in the most com
monly occurring epithelial tumors of the human ovary. Expression of p1
6 mRNA, examined by RT-PCR, was significantly reduced in 15 of the 48
tumors. Aberrant expression of p16 protein, detected by immunohistoche
mistry, occurred in 22 of 60 tumors, more frequently in low-grade tumo
rs, and had significant correlation with low p16 mRNA expression. Hype
rmethylation of a site within the 5'-CpG island of the p16 gene was si
gnificantly associated with loss of p16 mRNA and protein expression. H
omozygous gene deletion, evaluated by differential PCR analysis, was f
ound in 2 tumors for the p16 gene and in 1 tumor for the p15 gene amon
g 70 ovarian tumors examined. PCR-SSCP analysis detected point mutatio
ns in p16 in 4 tumors and in p15 in 1 tumor. One was a 38-bp deletion,
from codons 48 to 60, in a mucinous tumor of low malignant potential;
another was a non-sense mutation in codon 60 in a mucinous adenocarci
noma. The remaining 2 mutations were mis-sense mutations, one in codon
58 and the other in codon 60, in 2 endometrioid adenocarcinomas. We c
onclude that inactivation of p16 by loss of p16 mRNA and protein expre
ssion as a consequence of hypermethylation of the 5'-CpG island, rathe
r than by gene deletion or point mutation, may play an important role
in the genesis of human ovarian epithelial tumors. (C) 1997 Wiley-Liss
, Inc.